LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 38

Search options

  1. Book ; Online: Comparative effectiveness review methods

    West, Suzanne L

    clinical heterogeneity

    (Methods research report ; AHRQ publication ; no. 10-EHC070-EF)

    2010  

    Abstract: OBJECTIVES: The Agency for Healthcare Research and Quality (AHRQ) funded the RTI International--University of North Carolina at Chapel Hill Evidence-based Practice Center to determine best practices for addressing clinical heterogeneity in systematic ... ...

    Institution United States. / Agency for Healthcare Research and Quality.
    RTI International-University of North Carolina Evidence-based Practice Center
    Author's details prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services; prepared by RTI International-University of North Carolina Evidence-based Practice Center; investigators, Suzanne L. West ... [et al.]
    Series title Methods research report
    AHRQ publication ; no. 10-EHC070-EF
    Abstract OBJECTIVES: The Agency for Healthcare Research and Quality (AHRQ) funded the RTI International--University of North Carolina at Chapel Hill Evidence-based Practice Center to determine best practices for addressing clinical heterogeneity in systematic reviews (SRs) and comparative effectiveness reviews (CERs). These best practices address critiques from patients, clinicians, policymakers, and others who assert that SRs typically focus on broad populations and, as a result, often lack information relevant to individual patients or patient subgroups. DATA SOURCES AND METHODS: We used numerous data sources. We abstracted information from guidance documents prepared by U.S. and international organizations engaged in preparing reviews. We searched MEDLINE(r) to identify studies on how to handle clinical heterogeneity and subgroup analyses. We reviewed more than 120 SRs conducted by AHRQ's Evidence-based Practice Centers (EPCs), the Cochrane Collaboration, the Drug Effectiveness Review Project, the United Kingdom's National Institute for Health and Clinical Excellence and others that we identified from the Centre for Reviews and Dissemination Database of Abstracts of Reviews of Effects and Health Technology Assessment. We reviewed peer and public review comments from AHRQ's Scientific Review Center for three CERs, and we conducted key informant interviews with authors of six SRs prepared by AHRQ's EPCs or international organizations. RESULTS: Clinical heterogeneity has been defined as the variation in study population characteristics, coexisting conditions, cointerventions, and outcomes evaluated across studies included in an SR or CER that may influence or modify the magnitude of the intervention measure of effect (e.g., odds ratio, risk ratio, risk difference). Statistical heterogeneity is defined as variability in the observed treatment effects beyond what would be expected by random error. The review organizations we studied varied in their inclusion of factors, in terms of the key questions and analysis that may modify the treatment-outcome association. They tended to give more consideration to demographic factors than to disease factors (e.g., disease severity, risk factors, coexisting disease, or cointerventions). Individual systematic reviewers whom we interviewed preferred a priori identification of effect modifiers to post hoc determination because of the latter's data-dredging nature and the possibility of type 1 error when many subgroups are evaluated. Many publications that we identified through our literature searches did indicate that analysis of individual patient-level data in meta-analyses does allow better assessment of clinical heterogeneity, but the time, cost, and difficulty in obtaining these data are often prohibitive. CONCLUSIONS: Identifying factors that may influence the treatment-outcome association is important to clinicians and patients because it helps them understand which patients will benefit most, who is least likely to benefit, and who is at greatest risk of experiencing adverse outcomes. Clear evidence-based guidance on addressing clinical heterogeneity in SRs and CERs is not available currently but would be valuable to AHRQ's EPCs and to others conducting SRs internationally.
    MeSH term(s) Meta-Analysis as Topic ; Population Characteristics ; Review Literature as Topic
    Language English
    Publisher Agency for Healthcare Research and Quality
    Publishing place Rockville, MD
    Document type Book ; Online
    Note Title from PDF title page. ; "Contract No. 290-2007-10056-I." ; "September 2010."
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  2. Article ; Online: Did Arkansas' Medicaid Patient-Centered Medical Home Program Have Spillover Effects on Commercially Insured Enrollees?

    Hinde, Jesse M / West, Nathan / Arbes, Samuel J / Kluckman, Marianne / West, Suzanne L

    Inquiry : a journal of medical care organization, provision and financing

    2020  Volume 57, Page(s) 46958019900753

    Abstract: Patient-centered medical homes are increasingly being implemented by state Medicaid programs to incentivize high-quality, coordinated care and ultimately lower health care spending. This study examined whether the Arkansas Medicaid Patient-Centered ... ...

    Abstract Patient-centered medical homes are increasingly being implemented by state Medicaid programs to incentivize high-quality, coordinated care and ultimately lower health care spending. This study examined whether the Arkansas Medicaid Patient-Centered Medical Home Program's practice-wide transformation activities had spillover effects on commercial beneficiaries. We used difference-in-differences to compare utilization and expenditures of commercially insured enrollees as their practices received Medicaid patient-centered medical home certification on a rolling basis between 2014 and 2016. We found a 5.7% increase in outpatient visits and 13% higher expenditures among early adopting practices. Even without associated reductions in costly emergency department visits or inpatient hospital admissions, decisionmakers should not lose sight of the potential value of increased engagement in and coordination of professional services for a population with high unmet health needs. Our results also emphasize that states can leverage Medicaid to spur system-wide transformation, and the investments generate spillover effects beyond those covered directly by Medicaid.
    MeSH term(s) Arkansas ; Emergency Service, Hospital ; Health Expenditures/statistics & numerical data ; Hospitalization ; Humans ; Insurance Claim Review/statistics & numerical data ; Medicaid/economics ; Medicaid/statistics & numerical data ; Patient Acceptance of Health Care/statistics & numerical data ; Patient-Centered Care/statistics & numerical data ; Quality of Health Care/organization & administration ; United States
    Language English
    Publishing date 2020-01-16
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 42153-4
    ISSN 1945-7243 ; 0046-9580
    ISSN (online) 1945-7243
    ISSN 0046-9580
    DOI 10.1177/0046958019900753
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Unintended Effects of Communicating About Drug Safety Issues: A Critical Review of the Literature.

    DeFrank, Jessica T / McCormack, Lauren / West, Suzanne L / Lefebvre, Craig / Burrus, Olivia

    Drug safety

    2019  Volume 42, Issue 10, Page(s) 1125–1134

    Abstract: Communications about the safety and effectiveness of human drugs can influence patients' and prescribers' perceptions and behaviors, which in turn can affect the public's health more broadly. We conducted a critical review of the literature on the ... ...

    Abstract Communications about the safety and effectiveness of human drugs can influence patients' and prescribers' perceptions and behaviors, which in turn can affect the public's health more broadly. We conducted a critical review of the literature on the unintended effects from communicating information to the public about safety issues with prescription and over-the-counter drugs. We searched PubMed for peer-reviewed studies published from 1990 to 2017 where study authors reported probable unintended effects of communicating drug safety. The types of communications included in these studies were news reports, direct-to-consumer advertisements, and those released by government agencies. Among the 26 studies identified, the most commonly reported unintended effects were decreased drug use or discontinuation. Other unintended effects included spillover to populations not targeted by the communications (e.g., discontinuation of antidepressants among adults following communications concerning use among youth), shifts in clinical diagnoses (e.g., fewer diagnoses of depression), increased use of alternative therapies, and other undesirable behaviors (e.g., possible increased suicide attempts because antidepressants were discontinued). Limitations to the literature include the inability to establish causation or to isolate the effects of multiple communication sources and messages. Further, because the intended effect of many communications was not known, our study was limited by challenges in defining some effects as unintended. Most studies used health insurer claims data to identify unintended effects of communications, which provide an incomplete picture; few used self-reported or other methodologies that could help illuminate the reasons underlying the effects observed in the claims data. Best practices for communicating about the potential benefits and harms of drugs in a manner that minimizes negative unintended effects are needed to protect and improve public health.
    MeSH term(s) Drug-Related Side Effects and Adverse Reactions ; Health Behavior ; Health Communication/methods ; Humans ; Public Health ; United States
    Language English
    Publishing date 2019-05-26
    Publishing country New Zealand
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 1018059-x
    ISSN 1179-1942 ; 0114-5916
    ISSN (online) 1179-1942
    ISSN 0114-5916
    DOI 10.1007/s40264-019-00840-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Early impact of the implementation of Medicaid episode-based payment reforms in Arkansas.

    Toth, Matt / Moore, Paul / Tant, Elizabeth / Rutledge, Regina / Beil, Heather / Arbes, Sam / West, Nathan / West, Suzanne L

    Health services research

    2020  Volume 55, Issue 4, Page(s) 556–567

    Abstract: Objective: To evaluate episode-based payments for upper respiratory tract infections (URI) and perinatal care in Arkansas's Medicaid population.: Study setting: Upper respiratory infection and perinatal episodes among Medicaid-covered individuals in ... ...

    Abstract Objective: To evaluate episode-based payments for upper respiratory tract infections (URI) and perinatal care in Arkansas's Medicaid population.
    Study setting: Upper respiratory infection and perinatal episodes among Medicaid-covered individuals in Arkansas and comparison states from fiscal year (FY) 2011 to 2014.
    Study design: Cross-sectional observational analysis using a difference-in-difference design to examine outcomes associated with URI and perinatal episodes of care (EOC) from 2011 to 2014. Key dependent variables include antibiotic use, emergency department visits, physician visits, hospitalizations, readmission, and preventive screenings.
    Data collection: Claims data from the Medicaid Analytic Extract for Arkansas, Mississippi, and Missouri from 2010 to 2014 with supplemental county-level data from the Area Health Resource File (AHRF).
    Principal findings: The URI EOC reduced the probability of antibiotic use (marginal effect [ME] = -1.8, 90% CI: -2.2, -1.4), physician visits (ME = 0.6, 90% CI: -0.8, -0.4), improved the probability of strep tests for children diagnosed with pharyngitis (ME = 9.4, 90% CI: 8.5, 10.3), but also increased the probability of an emergency department (ED) visit (ME = 0.1, 90% CI: 0.1, 0.2), relative to the comparison group. For perinatal EOCs, we found a reduced probability of an ED visit during pregnancy (ME = 0.1, 90% CI: -0.2, -0.0), an increased probability of screening for HIV (ME = 6.2, 90% CI: 4.0, 8.5), chlamydia (ME = 9.5, 90% CI: 7.2, 11.8), and group B strep-test (ME = 2.6, 90% CI: 0.5, 4.6), relative to the comparison group. Predelivery and postpartum hospitalizations also increased (ME = 1.2, 90% CI: 0.4, 2.0; ME = 0.4, 90% CI: 0.0, 0.8, respectively), relative to the comparison group.
    Conclusion: Upper respiratory infection and perinatal EOCs for Arkansas Medicaid beneficiaries produced mixed results. Aligning shared savings with quality metrics and cost-thresholds may help achieve quality targets and disincentivize over utilization within the EOC, but may also have unintended consequences.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Arkansas ; Cross-Sectional Studies ; Emergency Service, Hospital/economics ; Emergency Service, Hospital/statistics & numerical data ; Episode of Care ; Fee-for-Service Plans/economics ; Fee-for-Service Plans/statistics & numerical data ; Female ; Hospitalization/economics ; Hospitalization/statistics & numerical data ; Humans ; Male ; Medicaid/economics ; Medicaid/statistics & numerical data ; Middle Aged ; Perinatal Care/economics ; Perinatal Care/statistics & numerical data ; Pregnancy ; Respiratory Tract Infections/economics ; Retrospective Studies ; United States
    Language English
    Publishing date 2020-05-21
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Observational Study ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 410435-3
    ISSN 1475-6773 ; 0017-9124
    ISSN (online) 1475-6773
    ISSN 0017-9124
    DOI 10.1111/1475-6773.13296
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Comparing record linkage software programs and algorithms using real-world data.

    Karr, Alan F / Taylor, Matthew T / West, Suzanne L / Setoguchi, Soko / Kou, Tzuyung D / Gerhard, Tobias / Horton, Daniel B

    PloS one

    2019  Volume 14, Issue 9, Page(s) e0221459

    Abstract: Linkage of medical databases, including insurer claims and electronic health records (EHRs), is increasingly common. However, few studies have investigated the behavior and output of linkage software. To determine how linkage quality is affected by ... ...

    Abstract Linkage of medical databases, including insurer claims and electronic health records (EHRs), is increasingly common. However, few studies have investigated the behavior and output of linkage software. To determine how linkage quality is affected by different algorithms, blocking variables, methods for string matching and weight determination, and decision rules, we compared the performance of 4 nonproprietary linkage software packages linking patient identifiers from noninteroperable inpatient and outpatient EHRs. We linked datasets using first and last name, gender, and date of birth (DOB). We evaluated DOB and year of birth (YOB) as blocking variables and used exact and inexact matching methods. We compared the weights assigned to record pairs and evaluated how matching weights corresponded to a gold standard, medical record number. Deduplicated datasets contained 69,523 inpatient and 176,154 outpatient records, respectively. Linkage runs blocking on DOB produced weights ranging in number from 8 for exact matching to 64,273 for inexact matching. Linkage runs blocking on YOB produced 8 to 916,806 weights. Exact matching matched record pairs with identical test characteristics (sensitivity 90.48%, specificity 99.78%) for the highest ranked group, but algorithms differentially prioritized certain variables. Inexact matching behaved more variably, leading to dramatic differences in sensitivity (range 0.04-93.36%) and positive predictive value (PPV) (range 86.67-97.35%), even for the most highly ranked record pairs. Blocking on DOB led to higher PPV of highly ranked record pairs. An ensemble approach based on averaging scaled matching weights led to modestly improved accuracy. In summary, we found few differences in the rankings of record pairs with the highest matching weights across 4 linkage packages. Performance was more consistent for exact string matching than for inexact string matching. Most methods and software packages performed similarly when comparing matching accuracy with the gold standard. In some settings, an ensemble matching approach may outperform individual linkage algorithms.
    MeSH term(s) Algorithms ; Databases, Factual/statistics & numerical data ; Electronic Health Records/standards ; Electronic Health Records/statistics & numerical data ; Humans ; Medical Record Linkage/methods ; Medical Record Linkage/standards ; Software
    Language English
    Publishing date 2019-09-24
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0221459
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Engaging stakeholders in pharmacoepidemiology research: Current state and recommendations.

    Camelo Castillo, Wendy / Heath, Nicholas / Kim, John / Yang, Kimberly / Ritchey, Mary E / dosReis, Susan / Santanello, Nancy / West, Suzanne L

    Pharmacoepidemiology and drug safety

    2019  Volume 28, Issue 6, Page(s) 766–776

    Abstract: Purpose: Given current efforts to enhance patient-centered care and shared decision-making, the International Society of Pharmacoepidemiology Workgroup on Patient Engagement assessed patient and other stakeholder engagement in pharmacoepidemiology ... ...

    Abstract Purpose: Given current efforts to enhance patient-centered care and shared decision-making, the International Society of Pharmacoepidemiology Workgroup on Patient Engagement assessed patient and other stakeholder engagement in pharmacoepidemiology research and provides recommendations for the field.
    Methods: A systematic review used MEDLINE and EMBASE to identify published literature from 2005 to 2016 addressing how stakeholders-patients, caregivers, and others-assisted researchers conducting pharmacoepidemiologic research. Three pairs of Workgroup members screened titles and abstracts to select articles for full-text review and analysis. Two Workgroup members abstracted the following data: research focus, characterization and role of stakeholders, and type(s) of engagement strategy employed. Data were summarized descriptively.
    Results: We identified 5717 references for abstract screening. Of these, 69 met the criteria for full-text screening, and 11 were selected for data abstraction. Of these 11 studies, seven focused on the development of a research agenda and eight had stakeholders react or advise on an aspect of the study. Although patients were the most commonly identified stakeholders, advocacy groups and health care professionals were also frequently identified. Some studies reported the engagement of other stakeholders, including local government or policy experts. Engagement strategies varied, with five studies using more than one strategy. Studies often did not indicate the involvement of stakeholders in developing the study design or with implementation.
    Conclusions: Currently, few pharmacoepidemiology publications mention patient or other stakeholder engagement in the design, analysis, or reporting of research. This suggests that there are opportunities to expand stakeholder engagement and/or increase the transparency of reporting stakeholder engagement.
    MeSH term(s) Decision Making, Shared ; Humans ; Patient Participation/methods ; Patient-Centered Care/methods ; Patient-Centered Care/organization & administration ; Pharmacoepidemiology/methods ; Pharmacoepidemiology/organization & administration ; Research Design
    Keywords covid19
    Language English
    Publishing date 2019-05-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Systematic Review
    ZDB-ID 1099748-9
    ISSN 1099-1557 ; 1053-8569
    ISSN (online) 1099-1557
    ISSN 1053-8569
    DOI 10.1002/pds.4786
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book: Systems to rate the strength of scientific evidence

    West, Suzanne L

    (Evidence report/technology assessment, ; no. 47 ; AHRQ publication ; no. 02-E016)

    2002  

    Institution United States. / Agency for Healthcare Research and Quality.
    Research Triangle Institute-University of North Carolina Evidence-based Practice Center
    Author's details prepared for Agency for Healthcare Research and Quality ; prepared by Research Triangle Institute-University of North Carolina Evidence-based Practice Center ; Suzanne West ... [et al.]
    Series title Evidence report/technology assessment, ; no. 47
    AHRQ publication ; no. 02-E016
    MeSH term(s) Evidence-Based Medicine
    Language English
    Size ix, 199 p. ;, 28 cm.
    Publisher U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality
    Publishing place Rockville, MD
    Document type Book
    Note "April 2002."
    ISBN 9781587631054 ; 1587631059
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  8. Article ; Online: Using health information exchanges to calculate clinical quality measures: A study of barriers and facilitators.

    Massoudi, Barbara L / Marcial, Laura H / Tant, Elizabeth / Adler-Milstein, Julia / West, Suzanne L

    Healthcare (Amsterdam, Netherlands)

    2016  Volume 4, Issue 2, Page(s) 104–108

    Abstract: Background: A key motivation for the large national investment in electronic health record systems is to promote electronic reporting of quality measures that can be used as the basis for moving to value-based payment. Given the fragmented delivery ... ...

    Abstract Background: A key motivation for the large national investment in electronic health record systems is to promote electronic reporting of quality measures that can be used as the basis for moving to value-based payment. Given the fragmented delivery system, robust quality reporting requires aggregating data across sites of care. Health information exchanges (HIEs) have emerged to facilitate exchange of clinical data across provider organizations and, therefore, should be well-positioned to support clinical quality measure reporting.
    Methods: By interviewing representatives from 36 HIEs across the United States, we aimed to determine whether HIEs are capable of computing National Quality Forum measures for 6 cardiovascular disease preventive services.
    Results: Eleven HIEs (30%) reported computing at least one CQM; six computed one or more of the measures, and no HIE computed a measure in each of the 6 areas. Barriers to computing CQMs included data quality, completeness, sharing, and transmission issues; organizational structure, maturity, and sustainability issues; and vendor issues.
    Conclusions: The ability to compute CQMs at the HIE level is still yet to be developed; currently, very few HIEs are able to do so for a variety of reasons. As HIE services expand and HIEs mature organizationally, the viability and utility of CQM reporting at the HIE level will increase.
    Implications: As the healthcare system migrates towards a value-based payment system these broad challenges will need to be addressed.
    Level of evidence: Cross-sectional semi-structured qualitative interviews.
    MeSH term(s) Cross-Sectional Studies ; Health Information Exchange/statistics & numerical data ; Health Information Systems/organization & administration ; Humans ; Information Dissemination ; Qualitative Research ; Quality of Health Care/organization & administration ; United States
    Language English
    Publishing date 2016-06
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2724773-9
    ISSN 2213-0772 ; 2213-0764 ; 2213-0772
    ISSN (online) 2213-0772 ; 2213-0764
    ISSN 2213-0772
    DOI 10.1016/j.hjdsi.2016.04.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.

    Lynch, Julie A / Berse, Brygida / Rabb, Merry / Mosquin, Paul / Chew, Rob / West, Suzanne L / Coomer, Nicole / Becker, Daniel / Kautter, John

    BMC cancer

    2018  Volume 18, Issue 1, Page(s) 306

    Abstract: Background: Tumor testing for mutations in the epidermal growth factor receptor (EGFR) gene is indicated for all newly diagnosed, metastatic lung cancer patients, who may be candidates for first-line treatment with an EGFR tyrosine kinase inhibitor. Few ...

    Abstract Background: Tumor testing for mutations in the epidermal growth factor receptor (EGFR) gene is indicated for all newly diagnosed, metastatic lung cancer patients, who may be candidates for first-line treatment with an EGFR tyrosine kinase inhibitor. Few studies have analyzed population-level testing.
    Methods: We identified clinical, demographic, and regional predictors of EGFR & KRAS testing among Medicare beneficiaries with a new diagnosis of lung cancer in 2011-2013 claims. The outcome variable was whether the patient underwent molecular, EGFR and KRAS testing. Independent variables included: patient demographics, Medicaid status, clinical characteristics, and region where the patient lived. We performed multivariate logistic regression to identify factors that predicted testing.
    Results: From 2011 to 2013, there was a 19.7% increase in the rate of EGFR testing. Patient zip code had the greatest impact on odds to undergo testing; for example, patients who lived in the Boston, Massachusetts hospital referral region were the most likely to be tested (odds ratio (OR) of 4.94, with a 95% confidence interval (CI) of 1.67-14.62). Patient demographics also impacted odds to be tested. Asian/Pacific Islanders were most likely to be tested (OR 1.63, CI 1.53-1.79). Minorities and Medicaid patients were less likely to be tested. Medicaid recipients had an OR of 0.74 (CI 0.72-0.77). Hispanics and Blacks were also less likely to be tested (OR 0.97, CI 0.78-0.99 and 0.95, CI 0.92-0.99), respectively. Clinical procedures were also correlated with testing. Patients who underwent transcatheter biopsies were 2.54 times more likely to be tested (CI 2.49-2.60) than those who did not undergo this type of biopsy.
    Conclusions: Despite an overall increase in EGFR testing, there is widespread underutilization of guideline-recommended testing. We observed racial, income, and regional disparities in testing. Precision medicine has increased the complexity of cancer diagnosis and treatment. Targeted interventions and clinical decision support tools are needed to ensure that all patients are benefitting from advances in precision medicine. Without such interventions, precision medicine may exacerbate racial disparities in cancer care and health outcomes.
    MeSH term(s) Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Diagnostic Tests, Routine/methods ; Diagnostic Tests, Routine/utilization ; Female ; Follow-Up Studies ; Health Services Accessibility/statistics & numerical data ; Health Status Disparities ; Healthcare Disparities/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Lung Neoplasms/diagnosis ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Male ; Medicare ; Middle Aged ; Mutation ; Precision Medicine ; Prognosis ; Protein Kinase Inhibitors/therapeutic use ; Receptor, Epidermal Growth Factor/antagonists & inhibitors ; Receptor, Epidermal Growth Factor/genetics ; Retrospective Studies ; United States ; Young Adult
    Chemical Substances Protein Kinase Inhibitors ; EGFR protein, human (EC 2.7.10.1) ; Receptor, Epidermal Growth Factor (EC 2.7.10.1)
    Language English
    Publishing date 2018-03-20
    Publishing country England
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S.
    ISSN 1471-2407
    ISSN (online) 1471-2407
    DOI 10.1186/s12885-018-4190-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Book: Pharmacotherapy for alcohol dependence

    West, Suzanne L

    (Evidence report/technology assessment ; no. 3 ; AHCPR publication ; no. 99-E004)

    1999  

    Institution United States. / Agency for Health Care Policy and Research.
    Research Triangle Institute
    Author's details prepared for Agency for Health Care Policy and Research ; prepared by Research Triangle Institute ; Suzanne L. West ... [et. al.]
    Series title Evidence report/technology assessment ; no. 3
    AHCPR publication ; no. 99-E004
    MeSH term(s) Alcoholism/drug therapy
    Language English
    Size x, 228 p. :, ill.
    Publisher U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research
    Publishing place Rockville, MD
    Document type Book
    Note "Contract no. 290-97-0011." ; "January 1999." ; Series numbering of no. 5 on cover is incorrect.
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

To top